Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 17/20 | 0.73 |
| ▸ | ADRA2C | P18825 | 17/20 | 0.73 |
| ▸ | ADRA2B | P18089 | 16/20 | 0.73 |
| ▸ | ADRA1D | P25100 | 14/20 | 0.73 |
| ▸ | ADRA1A | P35348 | 13/20 | 0.66 |
| ▸ | ADRA1B | P35368 | 12/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | HTR1A | P08908 | 1/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7031798 | 0.85 | ADRA2A (1.00) | ADRA2AADRA2CADRA2BADRA1DADRA1A | |
| SCHEMBL253111 | 0.85 | ADRA2A (0.82) | ADRA2AADRA2CADRA2BADRA1DADRA1A | |
| Brimonidine SCHEMBL20511531 | 0.80 | ADRA2A (1.00) | ADRA2AADRA2CADRA2BADRA1DADRA1A | |
| Brimonidine SCHEMBL24670 | 0.80 | ADRA2A (1.00) | ADRA2AADRA2CADRA2BADRA1DADRA1A | |
| Brimonidine SCHEMBL29374525 | 0.80 | ADRA2A (1.00) | ADRA2AADRA2CADRA2BADRA1DADRA1A | |
| Brimonidine SCHEMBL1685506 | 0.78 | ADRA2A (0.97) | ADRA2AADRA2CADRA2BADRA1DADRA1A | |
| Brimonidine SCHEMBL22616115 | 0.78 | ADRA2A (0.97) | ADRA2AADRA2CADRA2BADRA1DADRA1A | |
| SCHEMBL251823 | 0.78 | ADRA2A (0.75) | ADRA2AADRA2CADRA2BADRA1DADRA1A | |
| SCHEMBL7027501 | 0.78 | ADRA2A (0.61) | ADRA2AADRA2CADRA2BADRA1DADRA1A | |
| SCHEMBL7027488 | 0.78 | ADRA2A (0.61) | ADRA2AADRA2CADRA2BADRA1DADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1285657-A2 | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives | Allergan, Inc. (US) | 2003-02-26 | — | — | EP | disclosed |
| EP-0723447-B1 | USE OF (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINE DERIVATIVES | ALLERGAN INC (US) | 2002-12-11 | — | — | EP | disclosed |
| US-6323204-B1 | ANALGESICS, ANTIINFLAMMATORY AGENTS AND ANTIISCHEMIC AGENTS | ALLERGAN | 2001-11-27 | — | — | US | disclosed |
| EP-1140095-A1 | (2-IMIDAZOLINE-2-YLAMINO) QUINOXALINE DERIVATIVES FOR THE TREATMENT OF PAIN | Allergan Sales, Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000038684-A1 | (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINE DERIVATIVES FOR THE TREATMENT OF PAIN | ALLERGAN SALES, INC. (US) | 2000-07-06 | — | — | WO | disclosed |
| US-5773440-A | ANTIINFLAMMATORY AGENT | ALLERGAN (US) | 1998-06-30 | — | — | US | disclosed |
| US-5756503-A | ANALGESICS, ANESTHETICS, ANTIINFLAMMATORY AGENTS | ALLERGAN (US) | 1998-05-26 | — | — | US | disclosed |
| US-5714486-A | ADMINISTERING TO MAMMAL TO ANESTHETIZE CENTRAL NERVOUS SYSTEM | ALLERGAN (US) | 1998-02-03 | — | — | US | disclosed |
| US-5703077-A | ANALGESICS; ANESTHETICS; ANTIISCHEMIC AGENTS; DECONGESTANTS; ANTIINFLAMMATORY AGENTS | ALLERGAN (US) | 1997-12-30 | — | — | US | disclosed |
| US-5587376-A | ANTIISCHEMIC AGENTS, DECONGESTANTS | ALLERGAN (US) | 1996-12-24 | — | — | US | disclosed |
| US-5561132-A | ADMINISTERING TO ALTER RATE OF FLUID TRANSPORT IN GASTROINTESTINAL TRACT | ALLERGAN (US) | 1996-10-01 | — | — | US | disclosed |
| US-5552403-A | ANTIISCHEMIC AGENTS | ALLERGAN (US) | 1996-09-03 | — | — | US | disclosed |
| EP-0723447-A1 | METHODS FOR USING (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINE DERIVATIVES | Allergan (US) | 1996-07-31 | — | — | EP | disclosed |
| EP-0426390-B1 | Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure | ALLERGAN INC (US) | 1995-05-10 | — | — | EP | disclosed |
| WO-1995010280-A1 | METHODS FOR USING (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINE DERIVATIVES | ALLERGAN (US) | 1995-04-20 | — | — | WO | disclosed |
| US-5021416-A | Glaucoma | ALLERGAN, INC. (US) | 1991-06-04 | — | — | US | disclosed |
| EP-0426390-A2 | Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure | ALLERGAN, INC. (US) | 1991-05-08 | — | — | EP | disclosed |